Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
News
Events
Contact us
News
PrEP implant could enable long-term HIV protection
24 February 2023
Assembly Biosciences Nominates First Herpesvirus Development Candidate ABI-5366, a Long-Acting HSV-2 Helicase Inhibitor Targeting High-Recurrence Genital Herpes
17 February 2023
Reassuring Data on Durability of Long-Acting ART Every 8 Weeks
17 February 2023
ViiV Healthcare to Present First Head-to-head Data for New HIV Treatment Regimen Cabenuva Against Biktarvy
17 February 2023
Akari Therapeutics Announces Pre-Clinical Development Progress Toward Potential IND on Long-Acting PAS-Nomacopan for Geographic Atrophy (GA)
17 February 2023
New formulation can provide up to six months of full protection against HIV
10 February 2023
Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of T
03 February 2023
Study: Long-acting PrEP could reduce HIV incidence, AIDS deaths in sub-Saharan Africa
27 January 2023
Twice-Yearly Sunlenca Works Well for Initial HIV Treatment
27 January 2023
Newer stories
Older Stories